The Cooper Companies Stock Price and Value Analysis

The Cooper Companies (NYSE:COO) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold The Cooper Companies to reach your target.

Target type

COO Free Cash Flow Trend

Free Cash Flow trendline for COO
Free Cash Flow trendline for The Cooper Companies
CSV

Based on historical returns, we believe that The Cooper Companies can grow its free cash at a rate of about 4%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a modest rate.
  • This company is less known than others.
  • This company pays no dividend.

Inside the COO Numbers

COO Price
(The Cooper Companies stock price per share)
$58.88
[?] COO Fair Price
(based on intrinsic value)
$71.00
[?] COO Safety Price (based on a variable margin of safety) $42.60
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 2% higher than other Healthcare stocks
[?] PE Ratio versus Industry 16% lower than other Medical Instruments & Supplies stocks
[?] Cash Yield 3.03%
[?] Free Cash Flow Jitter 28%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

Recent Insider Activity

Open-market buys and sells reported by The Cooper Companies's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2024-09-10 Ricupati Agostino (SVP & CAO) Sell 1,601 $108.03

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 10,113,279 shares shorted. With 188,772,865 shares available for purchase and an average trading volume over the past 10 trading days of 1,928,930, it would take at least 5.2 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2008 711404 -28.4
2009 711404 114
2010 711404 170
2011 711404 237
2012 711404 216
2013 711404 306
2014 711404 316
2015 711404 218
2016 711404 327
2017 711404 406
2018 711404 478
2019 711404 512
2020 711404 271
2021 711404 511
2022 711404 442
2023 711404 317
2024 711404 393
2025 711404 470

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 18 fiscal years from 2008 to 2025 with positive net income, operating cash flow totaled $9,016 million against net income of $7,354 million, or 1.23 times.

In 2025, operating cash flow was 2.12 times net income, compared with 2.12 times for the earliest three years (2008 to 2010).

In 2025, capital expenditures were $362 million, 45.5% of operating cash flow of $796 million, which leaves an estimated $434 million after capex. Across the 18 years with reported capex, it averaged 42.9% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2008 64 96.5 125 1.51
2009 101 223 93.9 2.22
2010 113 268 73.8 2.37
2011 175 336 104 1.92
2012 248 315 99.8 1.27
2013 296 416 178 1.40
2014 270 455 238 1.69
2015 204 391 243 1.92
2016 274 510 153 1.86
2017 373 594 127 1.59
2018 140 669 194 4.78
2019 467 713 292 1.53
2020 238 487 310 2.04
2021 2,945 739 214 0.25
2022 386 692 242 1.79
2023 294 608 393 2.06
2024 392 709 421 1.81
2025 375 796 362 2.12

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2015 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $3,952 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 9 of those years with dividend payment facts, dividends paid totaled $26.6 million, 0.8% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 9 of those 9 years.

In 6 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $695 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, cash spent repurchasing shares was $290 million, 61.8% of estimated free cash flow of $470 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2015 218 2.9 67.3 70.2 32.1%
2016 327 2.9 n/a 2.9 0.9%
2017 406 2.9 55 57.9 14.3%
2018 478 2.9 n/a 2.9 0.6%
2019 512 3 156 159 31.1%
2020 271 3 47.8 50.8 18.7%
2021 511 3 24.8 27.8 5.4%
2022 442 3 78.5 81.5 18.4%
2023 317 3 n/a 3 0.9%
2025 470 n/a 290 290 61.8%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $1,047 million in 2008 and $4,092 million in 2025, a compound annual growth rate of 8.3% over 17 years.

Revenue rose 5.1% from 2024 to 2025.

Our estimated free cash flow was $470 million in 2025, 11.5% of revenue. In 2008 the estimated margin was negative 2.7%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2008 1,047 -28.4 -2.7%
2009 1,080 114 10.5%
2010 1,159 170 14.7%
2011 1,331 237 17.8%
2012 1,445 216 14.9%
2013 1,588 306 19.3%
2014 1,718 316 18.4%
2015 1,797 218 12.2%
2016 1,967 327 16.6%
2017 2,139 406 19.0%
2018 2,533 478 18.9%
2019 2,653 512 19.3%
2020 2,431 271 11.2%
2021 2,923 511 17.5%
2022 3,308 442 13.4%
2023 3,593 317 8.8%
2024 3,895 393 10.1%
2025 4,092 470 11.5%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $111 million against total liabilities of $4,156 million, or 2.7% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 33.5% of total assets in 2025, compared with 39.6% in 2009, a decrease of 6.1 percentage points.

Stockholders equity was $8,239 million in 2025, compared with $1,540 million in 2009, a rise of 434.9%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 4.2% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2009 2,552 3.9 1,012 1,540
2010 2,525 3.6 858 1,667
2011 2,625 5.2 687 1,937
2012 2,941 12.8 728 2,213
2013 3,137 77.4 714 2,423
2014 4,458 25.2 1,870 2,588
2015 4,463 16.4 1,790 2,674
2016 4,479 101 1,783 2,696
2017 4,859 88.8 1,683 3,176
2018 6,113 77.7 2,805 3,308
2019 6,275 89 2,646 3,629
2020 6,738 116 2,913 3,825
2021 9,606 95.9 2,664 6,942
2022 11,492 138 4,318 7,175
2023 11,659 121 4,108 7,551
2024 12,315 108 4,232 8,084
2025 12,395 111 4,156 8,239

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $58.88, our model's value equals that price if free cash flow grows an average of -3.6 percent a year over the 10 projection years. Our model assumes 4.4 percent a year for this stock, so the price implies growth of -3.6 percent, which is below the 4.4 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

A negative rate means the price matches our model's value only if free cash flow shrinks by that average each year over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $339 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $47.10 -25.8%
Current price $58.88 -3.6%
20 percent above the current price $70.66 4.2%
Our model (stored fair price) $71.00 4.4%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Of the 18 fiscal years we can see for The Cooper Companies under its current filer, 17 show positive free cash flow.

The price of $58.88 falls between the safe value ($42.60) and fair value ($71.00) for The Cooper Companies.

Comparing the first and last three years of data, average free cash flow rose sharply: $85.2 million at the start and $393 million most recently.

Year-to-year variability in free cash flow is uneven, measured at 28%.

Dividends are not in our data for The Cooper Companies.

Our value investing guide explains how to test these numbers against the filings themselves.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 2% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 16% below the average for stocks in the Medical Instruments & Supplies industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Medical Instruments & Supplies industry, the ones closest in market capitalization to The Cooper Companies, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
The Cooper Companies (COO) 11,196 20.2 - 3.0% 17% below
MSA Safety Incorporated (MSA) 6,550 21.8 1.2% 0.8% 277% above
Zimmer Biomet Holdings (ZBH) 19,134 25.5 0.9% - 51% above
DENTSPLY SIRONA (XRAY) 1,653 - 1.9% 33.8% 84% below
Alpha Pro Tech, Ltd. (APT) 61.2 12.2 - - 2% below
Edwards Lifesciences Corporation (EW) 58,564 59.2 - 0.9% 148% above
Intuitive Surgical (ISRG) 138,328 48.3 - 0.6% 244% above

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 711404.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 1 of the 18 years we have.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: COO annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in COO

Does The Cooper Companies have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: COO

This example shows how we apply the Trendshare checklist to COO: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 58.88
    • Market cap: $11B
    • EPS: 2.91
  2. Step 2 — Valuation checks

    • P/E: 20.234
    • FCF yield: 3.0%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.